parkinson's disease triple agonist glp-1 gip glucagon clinical trial Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative treatment Glucagon-like peptide-1 medicines in neurological
Description
Allulose &
GLP-1 secretion is stimulated by nutrient intake and exerts its effects on glucose homeostasis by stimulating insulin secretion, gastric emptying confiding the food intake, and -cell proliferation
It has a natural yellow pigment (dye) which also shows as bright yellow fluorescence under UV light.
Here, the authors examine the biological effects of incretins and other metabolic hormones, such as glucagon and amylin, as well as discussing current clinical data demonstrating the organ-protective effects of incretin drugs and their potential underlying mechanisms.
Find out here.
